Literature DB >> 21494808

Osteopathic manipulative treatment in patients with low back pain.

John C Licciardone.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21494808     DOI： 10.1007/s10067-011-1739-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  Single-blind randomised controlled trial of chemonucleolysis and manipulation in the treatment of symptomatic lumbar disc herniation.

Authors:  A K Burton; K M Tillotson; J Cleary
Journal:  Eur Spine J       Date:  2000-06       Impact factor: 3.134

2.  Osteopathic manipulative treatment for chronic low back pain: a randomized controlled trial.

Authors:  John C Licciardone; Scott T Stoll; Kimberly G Fulda; David P Russo; Jeff Siu; William Winn; Jon Swift
Journal:  Spine (Phila Pa 1976)       Date:  2003-07-01       Impact factor: 3.468

Review 3.  Osteopathy for musculoskeletal pain patients: a systematic review of randomized controlled trials.

Authors:  Paul Posadzki; Edzard Ernst
Journal:  Clin Rheumatol       Date:  2010-10-30       Impact factor: 2.980

4.  American Osteopathic Association guidelines for osteopathic manipulative treatment (OMT) for patients with low back pain.

Authors: 
Journal:  J Am Osteopath Assoc       Date:  2010-11

5.  Spinal manipulation for low back pain.

Authors:  F K Hoehler; J S Tobis; A A Buerger
Journal:  JAMA       Date:  1981-05-08       Impact factor: 56.272

Review 6.  Osteopathic manipulative treatment for low back pain: a systematic review and meta-analysis of randomized controlled trials.

Authors:  John C Licciardone; Angela K Brimhall; Linda N King
Journal:  BMC Musculoskelet Disord       Date:  2005-08-04       Impact factor: 2.362
  6 in total
  1 in total

1.  Osteopathy modulates brain-heart interaction in chronic pain patients: an ASL study.

Authors:  Francesco Cerritelli; Piero Chiacchiaretta; Francesco Gambi; Raoul Saggini; Mauro Gianni Perrucci; Antonio Ferretti
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.